# Study to Assess Switching to B/F/TAF in Treatment Experienced People With HIV Who Are at Least 65 Years of Age

> **NCT05147740** · PHASE4 · UNKNOWN · sponsor: **Tulika Singh, MD** · enrollment: 50 (estimated)

## Conditions studied

- HIV-1-infection

## Interventions

- **DRUG:** B/F/TAF

## Key facts

- **NCT ID:** NCT05147740
- **Lead sponsor:** Tulika Singh, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07-01
- **Primary completion:** 2022-12
- **Final completion:** 2022-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2021-12-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05147740

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05147740, "Study to Assess Switching to B/F/TAF in Treatment Experienced People With HIV Who Are at Least 65 Years of Age". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05147740. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*